Corrigendum to "Co-delivery of HIF1 α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer" [Biomaterials 46 (2015) 13-25]

Biomaterials. 2021 Dec 7;280:121296. doi: 10.1016/j.biomaterials.2021.121296. Online ahead of print.NO ABSTRACTPMID:34890971 | DOI:10.1016/j.biomaterials.2021.121296

Source: Biomaterials - December 10, 2021 Category: Materials Science Authors: Xiao Zhao Feng Li Yiye Li Hai Wang He Ren Jing Chen Guangjun Nie Jihui Hao Source Type: research